ONCT

Oncternal Therapeutics, Inc. Common Stock
ONCT

Overview Fund Activity
Delisted

ONCT was delisted on the 2nd of December, 2024.

Back to rankings

50 hedge funds and large institutions have $2.81M invested in Oncternal Therapeutics, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 13 increasing their positions, 8 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
50
Holders Change
-2
Holders Change %
-3.85%
% of All Funds
0.8%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
13
Reduced
8
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
PPW
Pasadena Private Wealth
California
$83.6K
2
RB
Richmond Brothers
Michigan
$148K
3
Geode Capital Management
Geode Capital Management
Massachusetts
$144K
4
Renaissance Technologies
Renaissance Technologies
New York
$94K
5
TSS
Two Sigma Securities
New York
$6.37K

Top Sellers

1
KCM
Kennedy Capital Management
Missouri
$0
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
$21K
3
Corient Private Wealth
Corient Private Wealth
Florida
$27.5K
4
Two Sigma Advisers
Two Sigma Advisers
New York
$29.5K
5
IIA
IPG Investment Advisors
California
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
DAM
51
Delta Asset Management
Tennessee
$2 -$2 – –
KCM
52
Kennedy Capital Management
Missouri
– -$203K -29,368 Closed
IIA
53
IPG Investment Advisors
California
– -$8.17K -1,185 Closed
FPCP
54
Fort Point Capital Partners
California
– -$6.92K -1,003 Closed
OIA
55
OneDigital Investment Advisors
Kansas
– -$4.05K -587 Closed
RhumbLine Advisers
56
RhumbLine Advisers
Massachusetts
– -$17 -3 Closed
1 2
3